cookiecutter666 t1_j3hba3c wrote on January 8, 2023 at 4:07 PM Reply to comment by ibkld63 in A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii So frustrating! This is the only thing that works for my autoimmune disease without horrific side effects. There were a couple months of misery for me. I also don’t like the judgement I get from the pharmacy now when I pick it up. Permalink Parent 19
cookiecutter666 t1_j3hba3c wrote
Reply to comment by ibkld63 in A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
So frustrating! This is the only thing that works for my autoimmune disease without horrific side effects. There were a couple months of misery for me. I also don’t like the judgement I get from the pharmacy now when I pick it up.